Aerometrex Delivers Record First Half Revenue and Strong EBITDA Growth
Aerometrex Limited (ASX: AMX) has released its preliminary, unaudited half-year results covering the period ended 31 December 2025, reporting record first-half revenue and substantial growth in EBITDA driven by improved sales execution and continued cost discipline. Performance was supported by strong new customer acquisition, particularly through the MetroMap subscription platform, which delivered a record Annual Contract Value of approximately AU$ 12.29 million, representing first-half growth of 35 percent on an annualised basis and an increase of 32 percent since December 2024. MetroMap statutory subscription revenue for the period is expected to be between AU$5.5 million and AU$5.9 million. Product competitiveness was enhanced through the rollout of oblique imagery, elevation, and contour line functionality, while operational efficiencies expanded capture areas and reduced publish times, with MetroMap now covering 94 percent of the population.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Aerometrex Delivers Record First Half Revenue and Strong EBITDA Growth
Aerometrex Limited (ASX: AMX) has released its preliminary, unaudited half-year results covering the period ended 31 December 2025, reporting record first-half revenue and substantial growth in EBITDA driven by improved sales execution and continued cost discipline. Performance was supported by strong new customer acquisition, particularly through the MetroMap subscription platform, which delivered a record Annual Contract Value of approximately AU$ 12.29 million, representing first-half growth of 35 percent on an annualised basis and an increase of 32 percent since December 2024. MetroMap statutory subscription revenue for the period is expected to be between AU$5.5 million and AU$5.9 million. Product competitiveness was enhanced through the rollout of oblique imagery, elevation, and contour line functionality, while operational efficiencies expanded capture areas and reduced publish times, with MetroMap now covering 94 percent of the population.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au